Kwang‐Ok Lee

Antitumor activity of HM781‐36B, a highly effective pan‐HER inhibitor in erlotinib‐resistant NSCLC and other EGFR‐dependent cancer models

Mi Young, Kwang‐Ok Lee, Mi‐Ra Kim et al. · International Journal of Cancer · 2011 · 79 citations · Full text

Medicine, Oncology, Pharmacology +13

Abstract LB-100: Discovery of HM61713 as an orally available and mutant EGFR selective inhibitor

Kwang‐Ok Lee, Mi Young, Mi‐Ra Kim et al. · Cancer Research · 2014 · 42 citations

Medicine, Oncology, Pharmacology +15

Syntheses and anti-MRSA activities of the C3 analogs of mansonone F, a potent anti-bacterial sesquiterpenoid: insights into its structural requirements for anti-MRSA activity

Dongyun Shin, Sun Nam Kim, Junghyun Chae et al. · Bioorganic & Medicinal Chemistry Letters · 2004 · 42 citations

Pharmacy, Medicinal Chemistry, Pharmacology +9

Novel Potent Antagonists of Transient Receptor Potential Channel, Vanilloid Subfamily Member 1:  Structure−Activity Relationship of 1,3-Diarylalkyl Thioureas Possessing New Vanilloid Equivalents

Young‐Ger Suh, Yong‐Sil Lee, Kyung‐Hoon Min et al. · Journal of Medicinal Chemistry · 2005 · 38 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +15

Discovery of A Novel Her-1/Her-2 Dual Tyrosine Kinase Inhibitor for the Treatment of Her-1 Selective Inhibitor-Resistant Non-small Cell Lung Cancer

Mi Young, Kwang‐Ok Lee, Jong Woo Kim et al. · Journal of Medicinal Chemistry · 2009 · 37 citations · Full text

Medicine, Medicinal Chemistry, Oncology +14